Tempt FDA stuff
Issues around approvals for drugs, biologics and medical devices.
FDA Special Status Programs (Part I: Overview)
June 16, 2019
Drug development companies often issue press releases touting that their drug has received special designations from the FDA citing terms such as “orphan” drug status, “fast track” approval and “breakthrough...